19 January 2021 in Journal of Cellular and Molecular Medicine
The recovery of blood supply after a period of myocardial ischaemia does not restore the heart function and instead results in a serious dysfunction called myocardial ischaemia‐reperfusion injury (IRI), which involves several complex pathophysiological processes. Mitochondria have a wide range of functions in maintaining the cellular energy supply, cell signalling and programmed cell death. When mitochondrial function is insufficient or disordered, it may have adverse effects on myocardial ischaemia‐reperfusion and therefore mitochondrial dysfunction caused by oxidative stress a core molecular mechanism of IRI. Peroxisome proliferator‐activated receptor gamma co‐activator 1α (PGC‐1α) is an important antioxidant molecule found in mitochondria. However, its role in IRI has not yet been systematically summarized. In this review, we speculate the role of PGC‐1α as a key regulator of mitonuclear communication, which may interacts with nuclear factor, erythroid 2 like ‐1 and ‐2 (NRF‐1/2) to inhibit mitochondrial oxidative stress, promote the clearance of damaged mitochondria, enhance mitochondrial biogenesis, and reduce the burden of IRI.
25 February 2022 in Current Pharmaceutical Biotechnology
Background: Low-molecular citrus pectin (LCP) is a pectin polysaccharide with low molec-ular weight, low degree of crux, and no branching. It is obtained by degrading natural citrus pectin (CP) through physical, chemical and enzymatic methods. LCP has received considerable attention in recent years due to its potential applications in the medical and biological fields. Methods: In our previous study, LCP was prepared from CP by using recombinant Bacillus subtilis pectate lyase B. Monosaccharide comparative analysis revealed that the galacturonic acid content of LCP was higher than that of CP. The cell viability effect of LCP was elucidated by using HepG2 cells and the Cell Counting Kit-8 (CCK-8) assay. Terminal deoxynucleotidyl transferase dUTP nick-end labeling (TUNEL) staining, Annexin V-FITC/PI staining, and flow cytometer propidium iodide stain-ing were performed to detect the effects of LCP on apoptosis and cell cycle arrest in HepG2 cells. Mi-tochondrial membrane potential (MMP) was observed through 5,5′,6,6′-tetrachloro-1,1′,3,3′-tetraethyl-imidacarbocyanine assay. Results & Discussion: The Mw of the prepared LCP was 7.6 kDa, which was significantly lower than that of CP (140 kDa). Cell viability decreased with the increase in the concentration of LCP. The half-inhibitory concentration of 1.46 ± 0.02 mg/mL was determined. Treatment with 1.6 mg/mL LCP in-duced the apoptosis of HepG2 cells with the inhibition rate of 83.10% ± 4.72%, and the cell cycle was arrested in the S phase. Furthermore, the MMP of HepG2 cells decreased with the increase in LCP concentration. Conclusion: The enzymatically prepared LCP could inhibit the proliferation of HepG2 cells. This study provided a partial experimental basis and reference for LCP to become a potential functional food for anti-liver cancer.
13 August 2025 in Cancer Science
Immunotherapy has opened new opportunities for the therapy of hepatocellular carcinoma (HCC), but is limited by the immunosuppressive microenvironment. Recent studies have reported that abnormal mitochondrial DNA (mtDNA) stress in tumor cells acts as an intercellular communication signal capable of affecting the tumor itself as well as the microenvironment, but the pathways by which mtDNA drives this process are currently unknown. In this study, we found that mtDNA is involved in hypoxia‐derived EVs‐mediated macrophage M2 phenotypic polarization promoting HCC progression. In vitro and in vivo experiments demonstrated that hypoxia promotes mtDNA release by enhancing mitochondrial quality control (MQC) signaling and subsequent exocytosis to macrophage via EVs. EVs carrying mtDNA activate macrophage cGAS/STING/NF‐κB pathway and promote M2 phenotypic polarization. In addition, we have modified the drug by using a nanodelivery system to make it tumor‐targeted and effective in inhibiting tumor growth in vivo. Taken together, our study reveals a critical role for EVs‐mtDNA in the formation of the immunosuppressive microenvironment in HCC under hypoxia and provides new evidence and solutions to improve sensitivity to immunotherapy for HCC.